BioMarin Pharmaceutical Ownership | Who Owns BioMarin Pharmaceutical?


OverviewForecastRevenueFinancialsChartTranscripts

BioMarin Pharmaceutical Ownership Summary


BioMarin Pharmaceutical is owned by 95.83% institutional investors, 0.78% insiders, and 3.39% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 12.54% of BMRN shares. Dodge & Cox Stock I is the top mutual fund, with 5.09% of its assets in BioMarin Pharmaceutical shares.

BMRN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBioMarin Pharmaceutical95.83%0.78%3.39%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de24.00M12.54%$1.32B
Blackrock22.74M12.04%$1.87B
Vanguard group19.37M10.17%$1.27B
Primecap management co/ca/15.77M8.24%$867.00M
Dodge & cox15.11M7.89%$830.50M
Viking global investors lp12.29M6.42%$675.50M
State street9.11M4.79%$598.94M
Ameriprise financial4.50M2.36%$295.80M
Norges bank3.57M1.87%$234.64M
Geode capital management3.29M1.73%$215.78M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Palo alto investors lp840.47K9.83%$46.20M
Boone capital management327.28K7.87%$23.14M
Eagle health investments lp419.21K6.75%$27.55M
Sio capital management225.11K4.73%$12.37M
Soleus capital management902.30K3.28%$49.60M
Camber capital management lp600.00K3.10%$32.98M
Novo660.00K2.56%$36.28M
Sector gamma as122.35K2.20%$6.73M
Viking global investors lp12.29M1.95%$675.50M
Motley fool wealth management475.95K1.58%$26.16M

Top Buyers

HolderShares% AssetsChange
Blackrock22.74M0.04%8.26M
Norges bank3.57M0.03%3.57M
Viking global investors lp12.29M1.95%1.49M
Voloridge investment management1.02M0.21%868.19K
Pictet asset management sa1.09M0.06%808.08K

Top Sellers

HolderShares% AssetsChange
Capital research global investors391.88K0.00%-8.76M
Elliott investment management---3.50M
Primecap management co/ca/15.77M0.69%-2.00M
Avoro capital advisors---1.46M
Jpmorgan chase1.55M0.01%-1.27M

New Positions

HolderShares% AssetsChangeValue
Norges bank3.57M0.03%3.57M$234.64M
Freestone grove partners lp335.51K0.14%335.51K$18.44M
Boone capital management327.28K7.87%327.28K$23.14M
Twinbeech capital lp299.23K0.37%299.23K$16.45M
M&g198.25K0.06%198.25K$10.90M

Sold Out

HolderChange
Blume capital management-2.00
Bryn mawr trust-2.00
Householder group estate & retirement specialist-3.00
Bokf, na-4.00
Abich financial wealth management-5.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025611-0.97%183,457,4080.41%951.05%322-5.57%1886.82%
Mar 31, 202511-98.11%305,544-99.83%-0.00%7-97.61%1-99.45%
Dec 31, 2024565-5.04%182,776,8923.30%951.11%2852.15%178-10.55%
Sep 30, 2024591-0.17%176,679,197-4.12%920.97%279-3.13%1957.14%
Jun 30, 2024583-2.35%184,215,3300.81%971.04%28513.55%178-13.17%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Dodge & Cox Stock I9.77M5.09%-
Capital Group Growth Fnd of Amer Comp8.28M4.32%741.56K
American Funds Growth Fund of Amer A8.28M4.32%741.56K
iShares Core S&P Mid-Cap ETF6.25M3.25%-11.22K
Vanguard US Total Market Shares ETF6.04M3.15%4.43K
Vanguard Total Stock Mkt Idx Inv6.02M3.14%-127.23K
Vanguard PRIMECAP Inv5.76M3.00%-1.33M
Vanguard Capital Opportunity Inv5.28M2.75%-223.03K
Vanguard Small Cap Index4.66M2.43%-29.83K
Capital Group AMCAP Composite4.49M2.36%-115.70K

Recent Insider Transactions


DateNameRoleActivityValue
May 20, 2025Burkhart Erin GVP, Chief Accounting OfficerSell$105.93K
May 02, 2025Hubbard Cristin EVP, Chief Commercial OfficerSell$17.72K
Mar 19, 2025Burkhart Erin GVP, Chief Accounting OfficerSell$92.62K
Mar 06, 2025Guyer Charles Greg EVP, Chief Technical OfficerSell$501.36K
Feb 24, 2025Burkhart Erin GVP, Chief Accounting OfficerSell$91.90K

Insider Transactions Trends


DateBuySell
2025 Q2-2
2025 Q1-3
2024 Q4-1
2024 Q3-1
2024 Q2-10

BMRN Ownership FAQ


Who Owns BioMarin Pharmaceutical?

BioMarin Pharmaceutical shareholders are primarily institutional investors at 95.83%, followed by 0.78% insiders and 3.39% retail investors. The average institutional ownership in BioMarin Pharmaceutical's industry, Biotech Stocks , is 306.59%, which BioMarin Pharmaceutical falls below.

Who owns the most shares of BioMarin Pharmaceutical?

BioMarin Pharmaceutical’s largest shareholders are Blackrock funding, inc. /de (24M shares, 12.54%), Blackrock (22.74M shares, 12.04%), and Vanguard group (19.37M shares, 10.17%). Together, they hold 34.75% of BioMarin Pharmaceutical’s total shares outstanding.

Does Blackrock own BioMarin Pharmaceutical?

Yes, BlackRock owns 12.04% of BioMarin Pharmaceutical, totaling 22.74M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.87B$. In the last quarter, BlackRock increased its holdings by 8.26M shares, a 57.05% change.

Who is BioMarin Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Palo alto investors lp is BioMarin Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 9.83% of its assets in 840.47K BioMarin Pharmaceutical shares, valued at 46.2M$.

Who is the top mutual fund holder of BioMarin Pharmaceutical shares?

Dodge & Cox Stock I is the top mutual fund holder of BioMarin Pharmaceutical shares, with 5.09% of its total shares outstanding invested in 9.77M BioMarin Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools